The dual-agonist question One theoretical question that researchers have not fully addressed is whether tirzepatide's GIP activation creates any additional considerations during breastfeeding
Some patients may need one approach, while others may need coordinated planning
calculated the risk to be 4.8/10,000 in groups taking GLP-1 RAs compared to 4.6/10,000 in the control groups, failing to show a statistically significant difference in aspiration or other complications between the two groups (Chang et al
However, because it can cause irritation, particularly on the delicate skin of the lips, it must be used carefully and only with a prescription
Ozempic is approved for type 2 diabetes, not weight loss
By suppressing hunger, increasing satiety, and stabilizing blood sugar, these medications help patients consume fewer calories without feeling deprived